Blockchain advancements to come from Tjoapack and Veratrak partnership

By Maggie Lynch

- Last updated on GMT

(Image:Getty/it_exx)
(Image:Getty/it_exx)
Tjoapack and Veratrak partnered to establish the use of blockchain technology across the pharmaceutical industry for the first time in a GxP environment.

Tjoapack a global packaging organization (CPO) will work with Veratrak, a UK-based technology company, on projects that use blockchain properties for transparent data collaboration across pharmaceutical supply chains. According to the company the partnership will initiate projects using blockchain properties more secure.

According to Dexter Tjoa, director of corporate strategy at Tjoapack, “We’re addressing the need for closer collaboration within the pharmaceutical industry by enabling easier and more transparent sharing of data in the form of master data, artwork, and batch records.”

The company will address this need for closer collaboration through multiple projects. The first project will use Vertrack’s document collaboration tool that uses blockchain properties to secure dating sharing.

“The tool will greatly reduce the lead time for new stock keeping unit (SKUs) and implementation time for product changes (such as artwork changes). This will enable us to become more flexible and reduce time to market for our customers”, ​explained Tjoa.

Veratrak’s tool has been built according to GAMP5 guidelines and is compliant with FDA part 11 regulations, according to the company.

According to a press release from Tjoapack, Veratrak’s tool will be the first global application of blockchain in a “Good practice (GxP) environment working with multiple organizations in the supply chain.”

Toja also told us that “Blockchain [technology] has other benefits for the industry than the above use case and we’ll be exploring this in the coming months and years together with Veratrak.”

Related news

Show more

Related products

Solution for challenging antibodies – Planova™ S20N

Solution for challenging antibodies – Planova™ S20N

Content provided by Asahi Kasei Medical Co., Ltd. | 24-Sep-2024 | White Paper

Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration performance for challenging molecules...

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Follow us

Products

View more

Webinars